Showing 1 - 10 of 903
The Affordable Care Act Marketplaces were introduced in 2014 as part of a reform of the U.S. individual health insurance market. While the individual market represents a small slice of the U.S. population, it has historically been the market segment with the lowest rates of take-up and greatest...
Persistent link: https://www.econbiz.de/10012455237
A central question in the debate over privatized Medicare is whether increased government payments to private Medicare Advantage (MA) plans generate lower premiums for consumers or higher profits for producers. Using difference-in-differences variation brought about by a sharp legislative...
Persistent link: https://www.econbiz.de/10012458198
Governments in many low- and middle-income countries are developing health insurance products as a complement to tax-funded, subsidized provision of health care through publicly operated facilities. This paper discusses two rationales for this transition. First, health insurance would boost...
Persistent link: https://www.econbiz.de/10014247916
2010 and 2011, the subsidies in Medicare Part D were revised, sharply changing the subsidy for diagnoses and demographic … characteristics. This paper uses the response of insurers to the subsidy update to estimate pass-through of government subsidies to …
Persistent link: https://www.econbiz.de/10012496082
The tendency of health care expenditures on the elderly to grow about 4 percent per annum more rapidly than the Gross Domestic Product could plunge the nation into a severe economic and social crisis within two decades. This paper describes recent growth in age-sex-specific health care...
Persistent link: https://www.econbiz.de/10012472058
A longstanding debate in health economics and health policy concerns how hospitals adjust prices with private insurers following reductions in public funding. A common argument is that hospitals engage in some degree of "cost-shifting," wherein hospitals increase prices with private insurers in...
Persistent link: https://www.econbiz.de/10012453410
Drug pricing in the U.S. is a persistently vexing policy problem. While there is agreement among many policy analysts that supra competitive prices are necessary to promote innovation; significant disagreements arise over how much pricing discretion prescription drug manufacturers should be...
Persistent link: https://www.econbiz.de/10012453473
We analyze potential reforms to Medicaid financing through the lens of fiscal federalism. Because substantial dollars …
Persistent link: https://www.econbiz.de/10012453748
Two of the three elements of the ACA's "premium stabilization program," reinsurance and risk corridors, are set to expire in 2017, leaving risk adjustment alone to protect plans against risk of high-cost cases. This paper considers potential modifications of the HHS risk adjustment methodology...
Persistent link: https://www.econbiz.de/10012456160
The Affordable Care Act introduces or expands taxes on incomes and full-time employment, beginning in 2014. The purpose of this paper is to characterize the new full-time employment taxes from the perspective of a household budget constraint, measure their magnitude, and assess their likely...
Persistent link: https://www.econbiz.de/10012458085